pubmed-article:17173931 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C1704319 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0003280 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0444626 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0439855 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0596788 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0015520 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:17173931 | lifeskim:mentions | umls-concept:C0162313 | lld:lifeskim |
pubmed-article:17173931 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17173931 | pubmed:dateCreated | 2007-1-29 | lld:pubmed |
pubmed-article:17173931 | pubmed:abstractText | NAPc2, an anticoagulant protein from the hematophagous nematode Ancylostoma caninum evaluated in phase-II/IIa clinical trials, inhibits the extrinsic blood coagulation pathway by a two step mechanism, initially interacting with the hitherto uncharacterized factor Xa exosite involved in macromolecular recognition and subsequently inhibiting factor VIIa (K(i)=8.4 pM) of the factor VIIa/tissue factor complex. NAPc2 is highly flexible, becoming partially ordered and undergoing significant structural changes in the C terminus upon binding to the factor Xa exosite. In the crystal structure of the ternary factor Xa/NAPc2/selectide complex, the binding interface consists of an intermolecular antiparallel beta-sheet formed by the segment of the polypeptide chain consisting of residues 74-80 of NAPc2 with the residues 86-93 of factor Xa that is additional maintained by contacts between the short helical segment (residues 67-73) and a turn (residues 26-29) of NAPc2 with the short C-terminal helix of factor Xa (residues 233-243). This exosite is physiologically highly relevant for the recognition and inhibition of factor X/Xa by macromolecular substrates and provides a structural motif for the development of a new class of inhibitors for the treatment of deep vein thrombosis and angioplasty. | lld:pubmed |
pubmed-article:17173931 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:language | eng | lld:pubmed |
pubmed-article:17173931 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17173931 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17173931 | pubmed:month | Feb | lld:pubmed |
pubmed-article:17173931 | pubmed:issn | 0022-2836 | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:TulinskyAA | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:BrayE WEW3rd | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:GeigerJ HJH | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:MurakamiM TMT | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:Rios-SteinerJ... | lld:pubmed |
pubmed-article:17173931 | pubmed:author | pubmed-author:WeaverS ESE | lld:pubmed |
pubmed-article:17173931 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17173931 | pubmed:day | 16 | lld:pubmed |
pubmed-article:17173931 | pubmed:volume | 366 | lld:pubmed |
pubmed-article:17173931 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17173931 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17173931 | pubmed:pagination | 602-10 | lld:pubmed |
pubmed-article:17173931 | pubmed:dateRevised | 2007-12-3 | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:meshHeading | pubmed-meshheading:17173931... | lld:pubmed |
pubmed-article:17173931 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17173931 | pubmed:articleTitle | Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum. | lld:pubmed |
pubmed-article:17173931 | pubmed:affiliation | Department of Physics, IBILCE/UNESP, São José do Rio Preto, SP 15054-000, Brazil. | lld:pubmed |
pubmed-article:17173931 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17173931 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17173931 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
entrez-gene:2159 | entrezgene:pubmed | pubmed-article:17173931 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17173931 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17173931 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17173931 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17173931 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17173931 | lld:pubmed |